Relevant bioinformatics analysis also confirmed that CACNA1D was highly expressed in prostate cancer, breast cancer, colorectal cancer, gastric cancer, lung cancer, uterine cancer, and other cancers (26). This evidence concerns the gene CACNA1D and breast carcinoma.